Related Experiment Video

Updated: Jul 15, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Class I HDAC SNP analysis in healthy donors compared to AML patients

C-L Dransfeld, M Schaich, A D Ho

    Leukemia
    |April 6, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    Related Experiment Videos

    Last Updated: Jul 15, 2026

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
    06:39

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

    Published on: October 3, 2018

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    Related Concept Videos

    Genome-wide Association Studies-GWAS01:11

    Genome-wide Association Studies-GWAS

    Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
    GWAS does not require the identification of the target gene involved in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.

    Acta neuropathologica communications·2024

    Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

    An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

    Immunohematology·2021

    Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approach.

    Journal of the Royal Society, Interface·2020

    Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018

    Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls.

    Leukemia·2026

    Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness.

    Leukemia·2026

    mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

    Leukemia·2026

    A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

    Leukemia·2026

    Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

    Leukemia·2026

    A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.

    Leukemia·2026

    Influencing Factors and Prediction Model Construction of Anxiety and Depression in Patients With Coronary Heart Disease Undergoing In-Stent Restenosis.

    Actas espanolas de psiquiatria·2026

    Corrigendum to "Differences in mortality by donor sex and age in heart transplantation: An individual patient data meta-analysis" [JHLT Open 11 (2026) 100466].

    JHLT open·2026

    Diagnosis, management, and prevention of Crimean-Congo haemorrhagic fever: a Delphi-based consensus study in Türkiye.

    EClinicalMedicine·2026

    Association between psychiatric comorbidities and the pharmacological secondary prevention of ischemic heart disease and cerebrovascular disease - an analysis of real-world health insurance prescription data in Germany.

    International journal of cardiology. Cardiovascular risk and prevention·2026

    Total transfemoral repair of thoracoabdominal aortic aneurysm and aortic dissection.

    Journal of vascular surgery cases and innovative techniques·2026

    Left Ventricular Thrombus Despite Prescribed Direct Oral Anticoagulant Therapy in Chronic Heart Failure With Reduced Ejection Fraction: A Case Report and Review of Risk Stratification.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us